BRIEF-Beijing Leadman Biochemistry to buy 23 pct stake in pharma device subsidiary for 92000 yuan – Reuters

Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:

View post:
BRIEF-Beijing Leadman Biochemistry to buy 23 pct stake in pharma device subsidiary for 92000 yuan - Reuters

Related Posts